SIMULTANEOUS EXPRESSION OF THYROID PEROXIDASE AND HUMAN-LEUKOCYTE ANTIGEN-DR BY HUMAN THYROID-CELLS - MODULATION BY THYROTROPIN, THYROID-STIMULATING ANTIBODY, AND INTERFERON-GAMMA

被引:11
作者
CHIOVATO, L
LAPI, P
MARIOTTI, S
DELPRETE, G
DECARLI, M
PINCHERA, A
机构
[1] UNIV PISA, IST ENDOCRINOL, PISA, ITALY
[2] UNIV FLORENCE, IST CLIN MED GEN & TERAPIA MED 3, FLORENCE, ITALY
关键词
D O I
10.1210/jc.79.2.653
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Major histocompatibility class II molecules human leukocyte antigen-DR (HLA-DR) are abnormally expressed by human thyroid cells (HTC) in autoimmune thyroid glands. The simultaneous expression of HLA-DR and organ-specific autoantigens such as thyroid peroxidase (TPO) by HTC might enable these cells to function as antigen-presenting cells, thus perpetuating the autoimmune process. The aim of the present study was to clarify the interplay of endocrine (TSH) and immune [TSab or interferon-gamma (IFN gamma)] factors on the expression of HLA-DR and TPO in HTC. Thyrocytes were cultured with super natants of T-cells cloned from the infiltrate of Hashimoto's glands, human recombinant IFN gamma, TSab, or TSH. These factors were added either alone or in different combinations and sequences. HLA-DR and TPO were identified in HTC by a double indirect immunofluorescence technique, using a monoclonal anti-HLA-DR antibody and human serum containing anti-TPO antibody, respectively. IFN gamma, either recombinant or produced by T-cell clones, induced HLA-DR appearance in thyrocytes, whereas TSH or TSab stimulated TPO expression. The appearance of HLA-DR induced by IFN gamma was accompanied by a progressive reduction of TPO despite stimulation by TSH or TSab. This decline reached a nadir after 9-10 days in different primary cultures. During this period, a percentage of cells ranging from 10-40% simultaneously expressed HLA-DR and TPO on their surface and in the cytoplasm. The inhibition of TPO expression and the appearance of HLA-DR induced by IFN gamma were rapidly reverted when TSH or TSab was substituted for interleukin in the culture medium and vice versa. We conclude that 1) the expression of TPO or HLA-DR in thyroid cells is a dynamic phenomenon that is differently influenced by TSH, TSab, and IFN gamma. It is the interplay of these factors in different follicles and during different periods of time that determines the expression of TPO alone, HLA-DR alone, or both molecules together in the same thyroid cell; 2) during exposure to TSH (or TSab) and IFN gamma, TPO and HLA-DR can be expressed simultaneously by thyroid cells for up to 7 days; and 3) the modulation of HLA-DR and TPO by supernatants of T-cells cloned from Hashimoto's glands is reproduced by IFN gamma alone.
引用
收藏
页码:653 / 656
页数:4
相关论文
共 22 条
[1]   FUNCTION OF DR-POSITIVE THYROCYTES FROM PATIENTS WITH GRAVES-DISEASE - QUANTITATIVE-ANALYSIS OF THYROID PEROXIDASE CONTENT BY FLUORESCENT PHOTOMETRY [J].
ASAKAWA, H ;
HANAFUSA, T ;
KUMA, K ;
KONO, N ;
TARUI, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (03) :614-618
[2]   INTERFERON-GAMMA REDUCES THE THYROID PEROXIDASE CONTENT OF CULTURED HUMAN THYROCYTES AND INHIBITS ITS INCREASE INDUCED BY THYROTROPIN [J].
ASAKAWA, H ;
HANAFUSA, T ;
KOBAYASHI, T ;
TAKAI, SI ;
KONO, N ;
TARUI, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (06) :1331-1335
[3]   INTERFERON-GAMMA INHIBITS THYROID-STIMULATING HORMONE-INDUCED MORPHOLOGICAL-CHANGES AND INDUCES THE EXPRESSION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II ANTIGEN IN THYROID-FOLLICLES IN SUSPENSION-CULTURE [J].
ASAKAWA, H ;
HANAFUSA, T ;
KATSURA, H ;
MIYAGAWA, J ;
OTSUKA, A ;
NAKAGAWA, C ;
ITOH, N ;
KONO, N ;
TARUI, S .
ENDOCRINOLOGY, 1991, 128 (03) :1409-1413
[4]   INTERFERON-GAMMA INHIBITS THYROTROPIN-INDUCED THYROIDAL PEROXIDASE GENE-EXPRESSION IN CULTURED HUMAN THYROCYTES [J].
ASHIZAWA, K ;
YAMASHITA, S ;
NAGAYAMA, Y ;
KIMURA, H ;
HIRAYU, H ;
IZUMI, M ;
NAGATAKI, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 69 (02) :475-477
[5]   DENOVO HLA CLASS-II AND ENHANCED HLA CLASS-I MOLECULE EXPRESSION IN SV40 TRANSFECTED HUMAN THYROID EPITHELIAL-CELLS [J].
BELFIORE, A ;
MAUERHOFF, T ;
PUJOLBORRELL, R ;
BADENHOOP, K ;
BUSCEMA, M ;
MIRAKIAN, R ;
BOTTAZZO, GF .
JOURNAL OF AUTOIMMUNITY, 1991, 4 (03) :397-414
[6]  
BOTTAZZO GF, 1983, LANCET, V2, P1115
[7]  
CHIOVATO L, 1989, CLIN EXP IMMUNOL, V76, P47
[8]   STUDIES ON THE MECHANISM RESPONSIBLE FOR THYROTROPIN-INDUCED EXPRESSION OF MICROSOMAL PEROXIDASE ANTIGEN IN FRTL-5 CELLS [J].
CHIOVATO, L ;
VITTI, P ;
LOMBARDI, A ;
CECCARELLI, P ;
CUCCHI, P ;
MARCOCCI, C ;
CARAYON, P ;
PINCHERA, A .
ENDOCRINOLOGY, 1988, 123 (02) :1140-1146
[9]   INCIDENCE OF ANTIBODIES BLOCKING THYROTROPIN EFFECT INVITRO IN PATIENTS WITH EUTHYROID OR HYPOTHYROID AUTOIMMUNE-THYROIDITIS [J].
CHIOVATO, L ;
VITTI, P ;
SANTINI, F ;
LOPEZ, G ;
MAMMOLI, C ;
BASSI, P ;
GIUSTI, L ;
TONACCHERA, M ;
FENZI, G ;
PINCHERA, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (01) :40-45
[10]  
Del Prete G F, 1989, Autoimmunity, V4, P267, DOI 10.3109/08916938909014703